Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723- Supply Disruption — Lupin Pharmaceuticals Inc. (M
Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723- Supply Disruption — Lupin Pharmaceuticals Inc. (M is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723-; Manufacturer: Lupin
| Drug name | Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723- |
|---|---|
| Manufacturer | Lupin Pharmaceuticals Inc. |
| Recall/Disruption reason | CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0376-2019 |
| Initiation date | 20190102 |
| Quantity affected | 287,784 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →